Moderna Q2 EPS $6.46 Beats $6.04 Estimate, Sales $4.40B Beat $4.28B Estimate
Moderna (NASDAQ:MRNA) reported quarterly earnings of $6.46 per share which beat the analyst consensus estimate of $6.04 by 6.95 percent. This is a 2183.87 percent increase over losses of $(0.31) per share from the same